(MedPage Today) — The bacillus Calmette-Guérin (BCG) vaccine, commonly used against tuberculosis, changed how immune cells behaved and altered markers linked to Alzheimer’s disease in a pilot study involving two open-label trials.
In a year…
Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/122069
Author :
Publish date : 2026-07-06 21:29:00
Copyright for syndicated content belongs to the linked Source.
